144 related articles for article (PubMed ID: 31830018)
21. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
[TBL] [Abstract][Full Text] [Related]
22. Influences on Intentions to Place Long-Acting Reversible Contraceptives: A Pilot Study Comparing According to Provider Specialty in Ohio.
Thompson CM; Broecker J; Dade M; Nottingham K
J Pediatr Adolesc Gynecol; 2018 Oct; 31(5):509-515. PubMed ID: 29580916
[TBL] [Abstract][Full Text] [Related]
23. Experiences With the Levonorgestrel Intrauterine System Among Clients, Providers, and Key Opinion Leaders: A Mixed-Methods Study in Nigeria.
Eva G; Nanda G; Rademacher K; Mackay A; Negedu O; Taiwo A; Dal Santo L; Saleh M; Palmer L; Brett T
Glob Health Sci Pract; 2018 Dec; 6(4):680-692. PubMed ID: 30591576
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
25. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
Ihongbe TO; Masho SW
J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of the views of healthcare professionals on the provision of long-acting reversible contraception.
Welsby C; Shipman J; Roe P
J Clin Nurs; 2020 May; 29(9-10):1499-1512. PubMed ID: 32065678
[TBL] [Abstract][Full Text] [Related]
27. General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK.
Middleton AJ; Naish J; Singer N
Eur J Contracept Reprod Health Care; 2011 Aug; 16(4):311-8. PubMed ID: 21585243
[TBL] [Abstract][Full Text] [Related]
28. A qualitative analysis of adolescents' opinions of proactive long-acting reversible contraceptive (LARC) provision.
Duncan R; Paterson H; Anderson L; Pickering N
N Z Med J; 2019 Jan; 132(1488):38-48. PubMed ID: 31851660
[TBL] [Abstract][Full Text] [Related]
29. Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas.
Vaaler ML; Kalanges LK; Fonseca VP; Castrucci BC
Womens Health Issues; 2012 Mar; 22(2):e157-62. PubMed ID: 22265180
[TBL] [Abstract][Full Text] [Related]
30. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
Pritt NM; Norris AH; Berlan ED
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
[TBL] [Abstract][Full Text] [Related]
31. Barriers to prescribing of long-acting reversible contraception (LARC) by general practitioner registrars: A cross-sectional questionnaire.
Turner R; Tapley A; Sweeney S; Magin P
Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):469-473. PubMed ID: 33590480
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
Sapkota S; Rajbhandary R; Lohani S
Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
[TBL] [Abstract][Full Text] [Related]
33. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
Coates C; Gordon CM; Simpson T
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
[TBL] [Abstract][Full Text] [Related]
34. Projections and opinions from 100 experts in long-acting reversible contraception.
Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA
Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195
[TBL] [Abstract][Full Text] [Related]
35. Helping patients select long-acting reversible contraceptives.
Sierra T
JAAPA; 2019 Apr; 32(4):23-27. PubMed ID: 30913144
[TBL] [Abstract][Full Text] [Related]
36. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
[TBL] [Abstract][Full Text] [Related]
37. Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usage.
Engstrand S; Kopp Kallner H
Contraception; 2018 May; 97(5):445-450. PubMed ID: 29409858
[TBL] [Abstract][Full Text] [Related]
38. The Latest in Teen Pregnancy Prevention: Long-Acting Reversible Contraception.
McClellan K; Temples H; Miller L
J Pediatr Health Care; 2018; 32(5):e91-e97. PubMed ID: 30180941
[TBL] [Abstract][Full Text] [Related]
39. Opportunity, satisfaction, and regret: Trying long-acting reversible contraception in a unique scientific circumstance.
Burke HM; Packer CA; Spector HL; Hubacher D
Women Health; 2019 Mar; 59(3):266-280. PubMed ID: 29920171
[TBL] [Abstract][Full Text] [Related]
40. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
